HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City

Presentation Event
2022 National Ryan White Conference on HIV Care & Treatment
Organization
NYC DOHMH
Presenter(s)
Sarah Wiant, Erica D'Aquila, Elizabeth Garcia, and Katey King
Description

The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.

Event Details

Event:
2022 National Ryan White Conference on HIV Care & Treatment
Track:
Population-Based Approaches for Improving Access, Engagement / Reengagement, and Health Outcomes
Abstract:
20444

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response
Did you use this approach in your work?
Not yet because
If no, why not?